Details for 2019155848
Up to date per 01.04.2026
Actions
Details for 2019155848
Granted/Registered
European Patent
17.07.2019 A
17.08.2022 B1
02.05.2014
US
201461987852 P
30.04.2015
US
201514700594
A61M 16/00 20060101AFI20190328BHEP
Owner
Mallinckrodt Pharmaceuticals Ireland LimitedCollege Business & Technology Park Cruiserath, Blanchardstown Dublin 15IE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
ACKER, Jaron M.350 S Hamilton St. Unit 1103 Madison, Wisconsin 53703US
TOLMIE, Craig R.1690 Red Oak Drive Stoughton, Wisconsin 53589US
Information about Fees